Novaremed AG
PrivateLast Round
PIPE
Jan 28, 2021
Company Overview
Novaremed AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a VC Round in September 2020.
Novaremed AG is a biopharmaceutical company that develops small bio-molecule drugs for the treatment of neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaremed AG Comparables
Compare Novaremed AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plumeria Therapeutics, Inc. | 85% | |
| NeuroFront Therapeutics | 84% | |
| 上海赛默罗生物科技有限公司 | 83% |
For institutional investors. Book with your work email.
Novaremed AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Jan 28, 2021 | ||||
| VC Round | Sep 15, 2020 | ||||
| VC Round | Sep 2, 2019 | ||||
| VC Round | Aug 23, 2018 | ||||
| VC Round | Apr 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$50M raised from Gemny.
- Sep 2, 2019
Raised $2.63M in a VC Round.
For institutional investors. Book with your work email.
Novaremed AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novaremed AG's valuation, stock price, and market status.
Is Novaremed AG a public or private company?
Novaremed AG is a private company.
What is the current stock price of Novaremed AG?
Novaremed AG is a private company, so its shares have no public market price. Caplight tracks Novaremed AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novaremed AG worth (valuation)?
Valuation information for Novaremed AG is not publicly available.
Can I buy Novaremed AG stock?
Novaremed AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novaremed AG's last funding round?
Novaremed AG's most recent funding round was PIPE on January 28, 2021.
Who are the main investors in Novaremed AG?
Investor information for Novaremed AG is not publicly disclosed.
Will Novaremed AG IPO soon?
No public IPO plans have been announced for Novaremed AG.
How can I track Novaremed AG secondary market activity?
Caplight tracks bids, offers, and trades in Novaremed AG's shares on secondary markets.